Frequency of Comorbid Conditions in Chronic Heart Failure
DOI:
https://doi.org/10.47494/mesb.v24i.1316Keywords:
comorbidity, chronic heart failure, ischemic heart disease, chronic kidney disease, functional class, fibrosis markers, anemia, creatinineAbstract
To study comorbid conditions in patients with chronic heart failure (CHF) living in regions with a hot climate, 323 patients were examined, including 150 men (46.43%), and 173 women (53.56%) aged under and over 60 years. Analyzes showed that in groups of patients with low hemoglobin albuminuria was detected in 35.6% of cases and the absence of anemia in 24.3% (p<0.05). Blood creatinine in patients under 60 years of age was 74.9 ± 17.7 and in 60 years and older 98 ± 21.9 μmol / l, there was an increase in the indicator depending on the CHF FC, which amounted to I-FC-83.2 ± 2.8, II-FC 101±3.8, III-FC 128±5.4, IV-FC 138.9±9.1 µmol/l (p<0.05). Thus, in patients with CHF, the incidence of comorbidity increases in proportion to the increase in age and functional class of chronic heart failure.
Downloads
References
Tosheva Khakima Bekmurodovna, Erkinova Nigora Erkinovna, Gadaev Abdigaffar Gadaevich, Djuraeva Nozima Oripovna, Khalilova Feruza Abdujalolovna. Comorbid States in Patients with Chronic Heart Failure. Regional Level of the Problem (Preliminary Study) // Journal of Cardiovascular Disease Research. – 2020 – Vol. 11, P. 59-65.
Gadaev A.G., ToshevaKh.B., ElmuradovF.Kh., Khalilova F.A. Fibrous changes in the kidneys in patients with CHF. Uzbekiston therapy of ahborotnomasi. 2018.-1-P.- 86-90.
Tosheva Kh.B., Xalilova F.A., Gadaev A.G., Erkinova N.E., Djuraeva N.O. Impact Of Chronic Heart Failure On Comorbidities In Hot Climates On The Quality Of Life And Clinical Condition Of Patients // European Journal of Molecular & Clinical Medicine. -2020 - Vol. 7, P. 1080-1089.
Belyalov F. I. Treatment of internal diseases in conditions of comorbidity: monograph. / F. I. Belyalov. – 8th ed. - Irkutsk: RIO IGIUVa, 2012. - 285 p.
Vertkin A.L., Rumyantsev M.A., Skotnikov A.S. Comorbidity in clinical practice. Part 1. - 2011. Archive of internal medicine. - 2011. - (1). - P. 16-20.
Gadaev A.G., Turakulov R.I., Kurbonov A.K. The occurrence of anemia in chronic heart failure and its negative impact on the course of the disease. Uzbek Medical Journal. - 2019 - 2. - P. 74 – 77
Garganeeva A.A., Bauer V.A., Borel K.N. Pandemic of the 21st century: chronic heart failure is a burden of modern society. Epidemiological aspects // Siberian Medical Journal (Tomsk). - 2014. - P. 8-12; E-mail: [email protected].
EfremovaYu.E. Treatment of edematous syndrome in chronic heart failure. breast cancer. - 2015 - 27. P. 1622-1624.
Lazebnik L.B. Aging and polymorbidity // Consiliummedicin - 2005. - 12. - P. 993-996.
Naumova L.A., Osipova O.N. Comorbidity: mechanisms of pathogenesis, clinical significance // Modern problems of science and education. - 2016. - 5. - P. 19-26.
Rakhimova D.A., TadzhikhodzhaevaYu.Kh., KhazratovU.Kh. The state of the cardiorespiratory and immune systems in elderly patients with chronic obstructive bronchitis during treatment with concentrated pulsed light. Act. problems of gerontology and geriatrics. Abstracts of reports of the republican scientific-practical conference. November 1-2, 2002 Tashkent. -p.95-96.
SharabchievYu.T., Antipov V.V., Antipova S.I. Comorbidity is an actual scientific and scientific-practical problem of medicine of the XXI century // Medical News - 2014. - 8. - P. 6-11.
Shutov A.M., Efremova E.V. Clinical features, quality of life and prognosis of patients with chronic cardiorenal syndrome // Nephrology. - 2015. - T. 19. - 2. - P. 64.
KhazratovU.Kh., ShodmonovKh.Z., Khamitova F.A., Niyazova G. Effect of phototherapy in elderly patients suffering from chronic obstructive pulmonary disease. Clinical gerontology. Moscow, 2006. No. 9. p.28-29.
Bayliss E. A. Description of barriers to self-care by persons with comorbid chronic diseases / [et al.] // Annals of Family Medicine. - 2003. - Vol. 1. - 1. - P. 15-21.
Dickson V. V. A qualitative meta-analysis of heart failure self-care practices among individuals with multiple comorbid conditions / V. V. Dickson, H. Buck, B. Riegel // J. of Cardiac Failure. - 2011. - Vol. 17. - 5. - P. 413-419.
EvansW. E. Pharmacogenomics - DrugDisposition, DrugTargets, and Side Effects / W. E. Ewans, H. L. McLeod // N. Eng. J. Med. – Vol. 3. - 2003. - Feb. – Vol. 48, No. 6. - P. 538-549.
Fortin M. [et al.]. A systematic review of prevalence studies on multimorbidity: Toward a more uniform methodology // Annals of Family Medicine. - 2012. - Vol. 10. - 2. - P. 142-151.
Fortin M., Bravo G., Hudon C. etai. Prevalence of multimorbidity among adults seen in family practice // Ann. fam. Med. - 2005. - 3. - P. 223-8.
F.A.Khalilova, R.S.Khotamova. Assessment of intracardiac hemodynamics and electrolyte balance in various hemodynamic types of chronic heart failure accompanied by anemia. Europe's Journal of Psychology, 2021, Vol. 17(3), 263-273.
Longjian L. Epidemiology of heart failure and scope of the problem // Cardiology Clinics. - 2014. - Vol. 32. - P. 1-8.
Lypez-Sendyn J. The heart failure epidemic // Mediographia. - 2011. - Vol. 33. - P. 363-369.
KhazratovU.Kh., Erkinova N.E., Tosheva H.B. The prevalence of xronic pyelonephritis in women with disturbed tolerance for glucose. Asian Journal of Multidimensional Research. November 2019. http://www.tarj.in 82.
Khotamova R.S. The Role of Folk Medicine in the Treatment of Patients with Cardiovascular Diseases // Central Asian Journal of Medical and Natural Science (ISSN:2660-4159) Oct. 14, 2021. Page: 280-283.
Gadaev A.G., Khalilova F.A., ElmuradovF.Kh., ToshevaKh.B. Structural and functional changes in the kidneys and heart in patients with CHF. Herald of therapy in Uzbekistan. 2018.-1-P.- 100-104.
Gadaev A.G., ElmuradovF.Kh., Erkinova N.E., ToshevaKh.B., Khalilova F.A. Diagnostic role of cystatin C and galectin-3 markers in combination in patients with CHF. Herald of therapy in Uzbekistan. 2018.-2-P.- 135-140.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
The work simultaneously licensed under a Creative Commons Attribution 4.0 International License
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
